SCHEMBL36825

SCHEMBL36825

C=Cc1cc(O[Si](C)(C)C(C)(C)C)c(O[Si](C)(C)C(C)(C)C)c(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.34

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.34
POLB P06746 1/20 0.34
TRPA1 O75762 1/20 0.33
DRD2 P14416 1/20 0.32
CA12 O43570 2/20 0.30
CA1 P00915 2/20 0.30
CA9 Q16790 2/20 0.30
MAPT P10636 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3679228 0.82 ALDH1A1 (0.35) NPSR1POLBDRD2CA12CA1
SCHEMBL36153 0.81 TRPA1 (0.42) TRPA1DRD2CA12CA1CA9
SCHEMBL38658450 0.80 NPSR1 (0.37) NPSR1POLBTRPA1DRD2MAPT
SCHEMBL36605 0.78 CA12 (0.38) CA12CA1CA9
SCHEMBL25365134 0.77 TRPA1 (0.50) TRPA1DRD2MAPTATM
SCHEMBL30540735 0.77 TRPA1 (0.50) TRPA1DRD2MAPTATM
SCHEMBL7332445 0.76 PPARA (0.32) NPSR1POLB
SCHEMBL16418139 0.73 ALDH1A1 (0.37) NPSR1POLBDRD2MAPT
SCHEMBL30540736 0.73 DRD2 (0.42) TRPA1DRD2
SCHEMBL25366327 0.73 DRD2 (0.40) TRPA1DRD2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117987-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2021-09-14 US disclosed
US-11028195-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2021-06-08 US disclosed
US-20190322777-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2019-10-24 US disclosed
US-20190233557-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2019-08-01 US disclosed
US-10227425-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2019-03-12 US disclosed
EP-2448900-B1 ANIONIC POLYMERIZATION INITIATORS AND PROCESSES BRIDGESTONE CORP (JP) 2017-04-26 EP disclosed
EP-2937365-B1 METHOD OF MAKING HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORP (JP) 2016-12-14 EP disclosed
EP-2589611-B1 Method for making hydroxyaryl functionalized polymers BRIDGESTONE CORP (JP) 2016-10-26 EP disclosed
US-9365660-B2 Anionic polymerization initiators and processes BRIDGESTONE CORPORATION (JP) 2016-06-14 US disclosed
EP-2937365-A1 METHOD OF MAKING HYDROXYARYL FUNCTIONALIZED POLYMERS Bridgestone Corporation (JP) 2015-10-28 EP disclosed
EP-2231719-B1 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORP (JP) 2015-07-29 EP disclosed
US-20150141582-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2015-05-21 US disclosed
US-8871871-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2014-10-28 US disclosed
EP-2589611-A1 Hydroxyaryl functionalized polymers Bridgestone Corporation (JP) 2013-05-08 EP disclosed
US-20120136128-A1 ANIONIC POLYMERIZATION INITIATORS AND PROCESSES BRIDGESTONE CORPORATION (JP) 2012-05-31 US disclosed
EP-2448900-A2 ANIONIC POLYMERIZATION INITIATORS AND PROCESSES Bridgestone Corporation (JP) 2012-05-09 EP disclosed
WO-2011008501-A2 ANIONIC POLYMERIZATION INITIATORS AND PROCESSES BRIDGESTONE CORPORATION (JP) 2011-01-20 WO disclosed
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORPORATION (JP) 2010-11-11 US disclosed
EP-2231719-A2 HYDROXYARYL FUNCTIONALIZED POLYMERS Bridgestone Corporation (JP) 2010-09-29 EP disclosed
WO-2009086490-A2 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORPORATION (JP) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190322777-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885
US-11028195-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL NPSR1 2277/4885POLB 2551/4885TRPA1 2609/4885
US-10227425-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885
US-20120136128-A1 ANIONIC POLYMERIZATION INITIATORS AND PROCESSES AP1M1, AP2M1, CCNE2 NPSR1 1981/4885POLB 762/4885TRPA1 570/4885
US-20150141582-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS HAAO, HCAR3, VCL NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885
US-11117987-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL NPSR1 2167/4885POLB 2420/4885TRPA1 2659/4885
US-20190233557-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL NPSR1 2277/4885POLB 2551/4885TRPA1 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.